Pramipexole and pergolide in the treatment of depression in Parkinson's disease:a national multicentre prospective randomized study.

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

REKTOROVÁ Irena REKTOR Ivan BAREŠ Martin DOSTÁL V. EHLER Edvard FANFRDLOVÁ Zuzana FIEDLER Jiří KLAJBLOVÁ Hana KULIŠŤÁK P. RESSNER Pavel SVÁTOVÁ J. URBÁNEK Karel VELÍSKOVÁ Jana

Year of publication 2003
Type Article in Periodical
Magazine / Source European Journal of Neurology
MU Faculty or unit

Faculty of Medicine

Citation
Field Neurology, neurosurgery, neurosciences
Keywords depression;dopamine receptor agonists;Parkinson's disease
Description An 8-month multicentre prospective randomized study aimed at comparing the effects of dopamine receptor agonists pramipexole as add-on to L-dopa therapyon depression in 41 non-demented patients suffering from both mild or moderate depression and advanced Parkinson's disease.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info